• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Exercise Attenuates Ribosomal Protein Six Phosphorylation in Fatty Liver Disease.运动可减轻脂肪性肝病中核糖体蛋白 S6 磷酸化。
Dig Dis Sci. 2020 Nov;65(11):3238-3243. doi: 10.1007/s10620-020-06226-1. Epub 2020 Apr 1.
2
TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.TXNIP/VDUP1 通过自噬和脂肪酸氧化来减轻脂肪性肝炎。
Autophagy. 2021 Sep;17(9):2549-2564. doi: 10.1080/15548627.2020.1834711. Epub 2020 Nov 16.
3
Lipotoxicity-induced STING1 activation stimulates MTORC1 and restricts hepatic lipophagy.脂毒性诱导的 STING1 激活刺激 MTORC1 并限制肝脏脂噬作用。
Autophagy. 2022 Apr;18(4):860-876. doi: 10.1080/15548627.2021.1961072. Epub 2021 Aug 12.
4
From overnutrition to liver injury: AMP-activated protein kinase in nonalcoholic fatty liver diseases.从营养过剩到肝损伤:AMP 激活的蛋白激酶在非酒精性脂肪性肝病中的作用。
J Biol Chem. 2020 Aug 21;295(34):12279-12289. doi: 10.1074/jbc.REV120.011356. Epub 2020 Jul 10.
5
DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis.DRD3(多巴胺受体 D3)而非 DRD2 通过抑制 MTORC1 激活自噬,从而保持蛋白质合成。
Autophagy. 2020 Jul;16(7):1279-1295. doi: 10.1080/15548627.2019.1668606. Epub 2019 Oct 2.
6
AMPK/mTOR pathway significance in healthy liver and non-alcoholic fatty liver disease and its progression.AMPK/mTOR 通路在健康肝脏和非酒精性脂肪性肝病及其进展中的意义。
J Gastroenterol Hepatol. 2023 Nov;38(11):1868-1876. doi: 10.1111/jgh.16272. Epub 2023 Jul 12.
7
Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis.肝 mTORC1 的激活通过双重调节 VLDL-TAG 分泌和从头合成脂质来防止 NASH。
Cell Mol Gastroenterol Hepatol. 2022;13(6):1625-1647. doi: 10.1016/j.jcmgh.2022.02.015. Epub 2022 Feb 28.
8
Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis.雷公藤红素通过激活 AMPK 减轻非酒精性脂肪性肝病,改善肝脏脂质代谢、炎症和肝纤维化。
Phytomedicine. 2021 Nov;92:153739. doi: 10.1016/j.phymed.2021.153739. Epub 2021 Sep 11.
9
Obesity-induced miR-802 directly targets AMPK and promotes nonalcoholic steatohepatitis in mice.肥胖诱导的 miR-802 直接靶向 AMPK 并促进小鼠非酒精性脂肪性肝炎。
Mol Metab. 2022 Dec;66:101603. doi: 10.1016/j.molmet.2022.101603. Epub 2022 Sep 17.
10
MicroRNA regulation of AMPK in nonalcoholic fatty liver disease.微小 RNA 对非酒精性脂肪性肝病 AMPK 的调控作用。
Exp Mol Med. 2023 Sep;55(9):1974-1981. doi: 10.1038/s12276-023-01072-3. Epub 2023 Sep 1.

引用本文的文献

1
Guts for Self-Eating: Role of Autophagy in Gastrointestinal Health and Disease.自我吞噬的肠道:自噬在胃肠道健康与疾病中的作用
Gastro Hep Adv. 2025 Mar 15;4(6):100654. doi: 10.1016/j.gastha.2025.100654. eCollection 2025.
2
AMPED study: Protocol for a randomized controlled trial of different doses of aerobic exercise training.AMPED 研究:不同剂量有氧运动训练的随机对照试验方案。
Hepatol Commun. 2024 Jun 19;8(7). doi: 10.1097/HC9.0000000000000464. eCollection 2024 Jul 1.
3
Motor skill learning modulates striatal extracellular vesicles' content in a mouse model of Huntington's disease.运动技能学习可调节亨廷顿病小鼠模型纹状体细胞外囊泡的内容物。
Cell Commun Signal. 2024 Jun 11;22(1):321. doi: 10.1186/s12964-024-01693-9.
4
Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease.磷酸化:脂肪性肝病发病机制和治疗的新靶点。
Lipids Health Dis. 2024 Feb 17;23(1):50. doi: 10.1186/s12944-024-02037-9.
5
Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway.圆山楂酸通过调控糖酵解和 TLR4/AP1 信号通路改善小鼠非酒精性脂肪性肝炎。
Lipids Health Dis. 2023 Dec 4;22(1):214. doi: 10.1186/s12944-023-01976-z.
6
Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia.运动在代谢相关脂肪性肝病(MAFLD)成人管理中的作用:来自澳大利亚运动与运动科学学会的立场声明。
Sports Med. 2023 Dec;53(12):2347-2371. doi: 10.1007/s40279-023-01918-w. Epub 2023 Sep 11.
7
Exercise Is Medicine for Nonalcoholic Fatty Liver Disease: Exploration of Putative Mechanisms.运动是治疗非酒精性脂肪肝的良药:潜在机制的探索。
Nutrients. 2023 May 24;15(11):2452. doi: 10.3390/nu15112452.
8
Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine.体力活动与非酒精性脂肪性肝病:美国运动医学学会圆桌会议声明。
Med Sci Sports Exerc. 2023 Sep 1;55(9):1717-1726. doi: 10.1249/MSS.0000000000003199.
9
Exercise as Medicine: The Impact of Exercise Training on Nonalcoholic Fatty Liver Disease.运动即良药:运动训练对非酒精性脂肪性肝病的影响。
Curr Hepatol Rep. 2020 Dec;19(4):402-411. doi: 10.1007/s11901-020-00543-9. Epub 2020 Sep 9.
10
Change in MRI-PDFF and Histologic Response in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis.非酒精性脂肪性肝炎患者的 MRI-PDFF 和组织学应答变化:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2021 Nov;19(11):2274-2283.e5. doi: 10.1016/j.cgh.2020.08.061. Epub 2020 Aug 31.

本文引用的文献

1
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.奥贝胆酸治疗非酒精性脂肪性肝炎:多中心、随机、安慰剂对照 3 期临床试验的中期分析。
Lancet. 2019 Dec 14;394(10215):2184-2196. doi: 10.1016/S0140-6736(19)33041-7. Epub 2019 Dec 5.
2
NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.NASH 成为女性肝移植首要原因:肝移植适应证的最新分析及种族和性别差异
Am J Gastroenterol. 2018 Nov;113(11):1649-1659. doi: 10.1038/s41395-018-0088-6. Epub 2018 Jun 8.
3
Physical deconditioning is the common denominator in both obese and overweight subjects with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的肥胖和超重患者都存在共同的身体失代偿因素。
Aliment Pharmacol Ther. 2018 Aug;48(3):290-299. doi: 10.1111/apt.14803. Epub 2018 May 24.
4
Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches.肠道微生物群和氧化应激在非酒精性脂肪性肝病向肝癌进展中的作用:当前和创新的治疗方法。
Redox Biol. 2018 May;15:467-479. doi: 10.1016/j.redox.2018.01.009. Epub 2018 Feb 3.
5
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.非酒精性脂肪性肝病的诊断与管理:美国肝病研究协会的实践指南
Hepatology. 2018 Jan;67(1):328-357. doi: 10.1002/hep.29367. Epub 2017 Sep 29.
6
AMP-activated protein kinase regulates lipid metabolism and the fibrotic phenotype of hepatic stellate cells through inhibition of autophagy.AMP激活的蛋白激酶通过抑制自噬来调节脂质代谢和肝星状细胞的纤维化表型。
FEBS Open Bio. 2017 May 11;7(6):811-820. doi: 10.1002/2211-5463.12221. eCollection 2017 Jun.
7
Editorial: Age and Non-Invasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: Time to Adjust the Clock?社论:非酒精性脂肪性肝病患者的年龄与纤维化无创标志物:是时候调整时钟了?
Am J Gastroenterol. 2017 May;112(5):752-754. doi: 10.1038/ajg.2017.60.
8
mTORC1 signaling in hepatic lipid metabolism.mTORC1 信号在肝脏脂质代谢中的作用。
Protein Cell. 2018 Feb;9(2):145-151. doi: 10.1007/s13238-017-0409-3. Epub 2017 Apr 22.
9
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review.有氧运动与抗阻运动治疗非酒精性脂肪性肝病:系统综述。
J Hepatol. 2017 Jan;66(1):142-152. doi: 10.1016/j.jhep.2016.08.023. Epub 2016 Sep 14.
10
Treatment of nonalcoholic fatty liver disease: role of AMPK.非酒精性脂肪性肝病的治疗:AMPK的作用
Am J Physiol Endocrinol Metab. 2016 Oct 1;311(4):E730-E740. doi: 10.1152/ajpendo.00225.2016. Epub 2016 Aug 30.

运动可减轻脂肪性肝病中核糖体蛋白 S6 磷酸化。

Exercise Attenuates Ribosomal Protein Six Phosphorylation in Fatty Liver Disease.

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, The Pennsylvania State University- Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA, 17033, USA.

Department of Public Health Sciences, The Pennsylvania State University- Milton S. Hershey Medical Center, Hershey, PA, USA.

出版信息

Dig Dis Sci. 2020 Nov;65(11):3238-3243. doi: 10.1007/s10620-020-06226-1. Epub 2020 Apr 1.

DOI:10.1007/s10620-020-06226-1
PMID:32239376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7529701/
Abstract

INTRODUCTION

Nonalcoholic fatty liver disease (NAFLD) is the leading cause of liver disease worldwide. Nonalcoholic steatohepatitis (NASH), is a more severe type of NAFLD. Exercise improves NASH, by reversing steatosis, and may arrest fibrosis. However, the mechanisms underlying these interactions are unknown. AMP-activated protein kinase (AMPK) is a fuel-sensing enzyme that is activated by energy stress. Mammalian target of rapamycin in complex 1 (mTORC1) is a nutrient sensor that regulates protein synthesis. In NASH, AMPK activity is low and mTORC1 is high. In healthy persons, exercise activates AMPK and suppresses mTORC1. We examined the effects of exercise on hepatic ribosomal protein S6 phosphorylation, a downstream target of AMPK and mTORC1 in patients with NASH.

METHODS

Three subjects with biopsy-proven NASH underwent a structured, 20-week aerobic exercise intervention, five-days a week for 30-min at a moderate intensity (40-55% of VO2max). Immunofluorescence staining for rpS6 phosphorylation in hepatic tissue was quantified by ImageJ software.

RESULTS

Following 20-weeks of aerobic exercise, rpS6 levels were significantly attenuated (3.9 ± 1.9 pre-exercise vs. 1.4 +/0.4 post-exercise, p = 0.04).

CONCLUSIONS

These findings suggest exercise modulates the AMPK/mTORC1 pathway in patients with NASH and may guide the design of future studies into the mechanism of how exercise improves NASH and possibly reverses fibrosis.

摘要

简介

非酒精性脂肪性肝病(NAFLD)是全球范围内导致肝病的主要原因。非酒精性脂肪性肝炎(NASH)是一种更严重的 NAFLD 类型。运动通过逆转脂肪变性改善 NASH,并可能阻止纤维化。然而,这些相互作用的机制尚不清楚。AMP 激活的蛋白激酶(AMPK)是一种受能量应激激活的燃料感应酶。雷帕霉素靶蛋白复合物 1(mTORC1)是一种营养传感器,可调节蛋白质合成。在 NASH 中,AMPK 活性降低,mTORC1 活性升高。在健康人群中,运动激活 AMPK 并抑制 mTORC1。我们研究了运动对 NASH 患者肝核糖体蛋白 S6 磷酸化的影响,该蛋白是 AMPK 和 mTORC1 的下游靶标。

方法

三名经活检证实患有 NASH 的患者接受了一项结构化的 20 周有氧运动干预,每周 5 天,每天 30 分钟,强度适中(40-55%的 VO2max)。使用 ImageJ 软件对肝组织中 rpS6 磷酸化的免疫荧光染色进行定量。

结果

有氧运动 20 周后,rpS6 水平显著降低(运动前 3.9±1.9 vs. 运动后 1.4+/0.4,p=0.04)。

结论

这些发现表明,运动可调节 NASH 患者的 AMPK/mTORC1 通路,并可能指导未来研究运动如何改善 NASH 以及可能逆转纤维化的机制。